The Cost of a Fortress Science Mentality

Our titanic national debt will eventually force hard decisions. Science funding will not be exempted. When that time comes, a public that has heard from the scientific community about why its work is valuable will more likely support science than one that hasn't. We cannot expect the public to respond positively if we have not told them our story. We can only do so through the media. Molecular biologist Bryan Sykes of Oxford University recently spent seven weeks working for a British televis

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Our titanic national debt will eventually force hard decisions. Science funding will not be exempted. When that time comes, a public that has heard from the scientific community about why its work is valuable will more likely support science than one that hasn't. We cannot expect the public to respond positively if we have not told them our story. We can only do so through the media.

Molecular biologist Bryan Sykes of Oxford University recently spent seven weeks working for a British television station under a Science and Technology Media Fellowship, sponsored by the British Association for the Advancement of Science. He has offered his colleagues sound advice on how to speak through the media ( New Scientist, November 26, 1987, pp. 67-68). Sykes is correct to point out that our reluctance to work with the press can only widen the gulf that now separates scientists from the rest of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies